Why Biogen Stock Popped Today
1 minuto de lectura
What happened?On Friday morning, Biogen (NASDAQ: BIIB) released an update regarding its Biologics License Application (BLA) for aducanumab as a potential treatment for Alzheimer’s disease (AD). The drugmaker wasn’t too forthcoming with details in this update — and there was certRead MoreMarketsMarkets Feed
Descubre más desde Espacioteca
Suscríbete y recibe las últimas entradas en tu correo electrónico.
